Altimmune, Inc. (ALT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Join SI Premium – FREE
Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.48), $0.01 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $2 thousand versus the consensus estimate of $867.83 thousand.
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Altimmune, Inc. (ALT) Tops Q2 EPS by 3c
- Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c
- LiqTech International (LIQT) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
